COMPANY PROFILE

Robocath

Explore full profile

Innovative solutions for the treatment of cardiovascular diseases

Rouen, FranceFounded 2009Biotech & Life Sciences

Valuation $100–250M Last recorded · 2020

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Robocath

Robocath is a medical technology startup that specializes in the development of robotic solutions for the treatment of vascular diseases such as heart attacks and strokes. Their primary product, R-One+, is a robotic unit designed to assist with Percutaneous Coronary Intervention (PCI), a procedure used to treat coronary artery diseases. The R-One+ robot is capable of accurately replicating hand movements, enhancing the precision and effectiveness of medical procedures.

Read full description

The company's robotic unit optimizes the placement of balloons and stents, two key components in PCI procedures. The robot's guidewire locking system ensures secure access to the lesion throughout the procedure, enhancing the safety and reliability of the treatment. The R-One+ has received positive feedback from healthcare professionals for its exceptional precision and ease of use.

Robocath operates in the healthcare market, specifically in the field of interventional cardiology. Their clients are primarily healthcare professionals and institutions that perform PCI procedures. The company's business model revolves around the development, production, and sale of their robotic units to these healthcare providers. They generate revenue through the sales of their robotic units and potentially through ongoing service and maintenance contracts.

In summary, Robocath is a promising startup in the medical technology sector, offering innovative robotic solutions that enhance the precision and safety of vascular disease treatments.

Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2009
Headquarters: Rouen, France
Employees: 59
Open positions: None listed
Dealroom signal: 64.5/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Surgery, Cardiology and cardiovascular, Non-Invasive medical devices and treatments, Medical Robots, Surgical Equipment, Tech for Hospitals and Clinics, Collaborative Robots, Physician Support Tools, Treatment Assistance
Business model: Manufacturing
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Apr 2026	$20M	—	Stereotaxis	↗
DEBTDebt	Dec 2021	$17M	—	European Investment Bank	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Robocath website traffic

Latest recorded traffic for Robocath is 830 monthly website visits, down 65.4% over the last three months. Robocath's team declined 4.8% over the past year.

Latest monthly visits830 3-month web change-65.4% 1-year team growth-4.8%

Monthly website visitsNov 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
QSQuantum SurgicalDemocratizes minimally invasive cancer treatment through preplanning, advanced robotic assistance, and tumor ablation confirmation	Montpellier, France	Operational	135	$46M	$176M
EReCential RoboticsDesigned the first all-in-one surgical platform combining 2D Fluoroscopy, 3D Imaging, and real-time navigation	Gières, France	Acquired
GRGanymed RoboticsGanymed retools orthopaedics with robotics. Their product is a compact, ergonomic, and cost-effective joint-replacement device. The robot's intelligence and perception are driven by computer vision	Paris, France	Operational
SRSpinEM RoboticsDeveloping a surgical robot for minimally invasive spinal surgery based on an innovative tracking system	Saint-Martin-d'Hères, France	Operational
ERExtremis Roboticsspecializing in research and development of a medical device in the field of surgical robotics of the foot	Saint-Martin-d'Hères, France	Operational
MSMoon SurgicalMoon Surgical, formerly kown as MastOR, aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics	Paris, France	Operational
MGMedineering GmbHDevelops, manufactures and markets an application-specific and convenient medical robotic portfolio	Munich, Germany	Acquired
RORobeautéWe are developing a sub millimetric microrobot that moves in the brain in curved lines (3D) with sub millimetric precision allowing to access complex areas of the brain in multiple locations to gather data and deliver cargos (micro-electrodes, drugs)	Paris, France	Operational